Macrophagic myofasciitis (MMF), a condition newly recognized in France, is manifested by diffuse myalgias and characterized by highly specific myopathological alterations which have recently been shown to represent an unusually persistent local reaction to intramuscular injections of aluminium-containing vaccines. Among 92 MMF patients recognized so far, eight of them, which included the seven patients reported here, had a symptomatic demyelinating CNS disorder. CNS manifestations included hemisensory or sensorimotor symptoms (four out of seven), bilateral pyramidal signs (six out of seven), cerebellar signs (four out of seven), visual loss (two out of seven), cognitive and behavioural disorders (one out of seven) and bladder dysfunction (one out of seven). Brain T(2)-weighted MRI showed single (two out of seven) or multiple (four out of seven) supratentorial white matter hyperintense signals and corpus callosum atrophy (one out of seven). Evoked potentials were abnormal in four out of six patients and CSF in four out of seven. According to Poser's criteria for multiple sclerosis, the diagnosis was clinically definite (five out of seven) or clinically probable multiple sclerosis (two out of seven). Six out of seven patients had diffuse myalgias. Deltoid muscle biopsy showed stereotypical accumulations of PAS (periodic acid-Schiff)-positive macrophages, sparse CD8+ T cells and minimal myofibre damage. Aluminium-containing vaccines had been administered 3-78 months (median = 33 months) before muscle biopsy (hepatitis B virus: four out of seven, tetanus toxoid: one out of seven, both hepatitis B virus and tetanus toxoid: two out of seven). The association between MMF and multiple sclerosis-like disorders may give new insights into the controversial issues surrounding vaccinations and demyelinating CNS disorders. Deltoid muscle biopsy searching for myopathological alterations of MMF should be performed in multiple sclerosis patients with diffuse myalgias.
The clinical and pathologic findings in a 34-year-old woman with basal ganglia degeneration and amyotrophic lateral sclerosis are reported. The duration of symptoms was 2 years. A maternal uncle had a parkinsonian syndrome with onset at 45 years of age. Neuropathologic examination revealed extensive neuronal loss and gliosis in the corpus Luysii. Nerve cell loss and gliosis also involved both parts of the globus pallidus, and the substantia nigra. The corticospinal tracts were demyelinated in the spinal cord, and neuronal loss was observed in the anterior horns. Only one similar case of pallido-luyso-nigral atrophy associated with amyotrophic lateral sclerosis has, to our knowledge, been reported previously. Such an association may represent more than a coincidental occurrence.
An 80-year-old hypertensive woman developed right hemiplegia and died 24 hours after admission. Neuropathologic examination revealed multiple cerebral infarcts of various ages and diffuse subcortical arteriosclerotic encephalopathy. Clusters of asymptomatic "expanding" lacunes, due to dilatation of the perivascular spaces, were found in both dentate nuclei. These cavities, which presented as space-occupying lesions, were surrounded by a single layer of flattened cells and contained 1 or more sections of normal-looking arterioles. Such a topographic grouping of lacunes in the dentate nucleus has not been described previously. The mechanism of widening of the perivascular compartment remains unclear; its occurrence in a hypertensive patient and its association with typical Binswanger's subcortical arteriosclerotic encephalopathy and severe atherosclerosis with multiple infarcts suggest a common pathophysiologic mechanism possibly including an alteration of the blood-brain barrier.(Stroke 1987;18:1087-1092) C erebral lacunes are usually considered to be old, small, deep cerebral infarcts 12 due to occlusive arterial lesions. 34 However, old hemorrhages can be a cause of lacunes and have been recently reviewed.5 Dilatations of perivascular spaces, well known since the historic paper of Marie 6 and the thesis of Ferrand, 7 have been reemphasized recently as a possible mechanism of genesis of cerebral lacunes. 89To avoid the semantic confusion that surrounds the term cerebral lacune, 10 a new neuropathologic classification has been proposed." 12 Lacunes due to dilatation of the perivascular space are usually asymptomatic. 8 A new type of space-occupying lacune due to dilatation of the perivascular space was described as an "expanding cerebral lacune" by Poirier et al. 9 In this initial report, the thalamo-mesencephalic "expanding lacunes" were responsible for clinical symptoms.In this article, we report a new case of expanding lacune involving the cerebellum with three major points of interest: 1) the lesion was asymptomatic, presenting as an incidental autopsy finding, 2) the topographic grouping of lacunes in the dentate nuclei had never been described, and 3) the lacunes were associated with Binswanger's subcortical arteriosclerotic encephalopathy (SAE) and multiple cerebral infarcts. Such an association in a hypertensive patient suggests com- Received March 5, 1987; accepted June 22, 1987. mon pathogenetic mechanisms as the origin of these various lesions. Report of a CaseAn 80-year-old woman known to be hypertensive for many years had received various antihypertensive treatments. She suffered from left ventricular failure and coronary insufficiency. She was admitted to the hospital on March 8, 1983, because of dyspnea. Blood pressure was 170/100 mm Hg. She became somnolent, then comatose, and developed right hemiparesis 24 hours after admission and died within a few hours. Computed tomography (CT) scan was not obtained.Postmortem examination revealed diffuse and severe atherosclerotic lesions in the thoracic ...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.